Clinical trial
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
NCT00563758 is registered in ClinicalTrials.gov with Hospital Authority, Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
- Lead sponsor
- Hospital Authority, Hong Kong
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 31, 2004
- Completion date
- February 28, 2006
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.